The Scientific Advisory Board is composed of leading epilepsy researchers from both academia and industry with expertise spanning a broad range of disciplines. The SAB members assess grant and investment opportunities and also share their expertise to guide researchers in most effectively advancing new therapy projects. The SAB also provides strategic direction to guide the programs of the organization.

• Gregory Bergey, M.D.:  Professor of Neurology, The Johns Hopkins Epilepsy Center
• Orrin Devinsky, M.D.:  Co-Founder; Vice President for Translational Programs; Professor of Neurology, Neurosurgery and Psychiatry and Director, NYU Comprehensive Epilepsy Center, New York University
• Joyce A. Cramer
  Consultant; Associate Research Scientist, Yale University School of Medicine
• Ray Dingledine, Ph.D.
  Chair, Department of Pharmacology, Emory University
• Robert Fisher, M.D., Ph.D.
  Professor of Neurology and Director, Stanford Comprehensive Epilepsy Center, Stanford University
• Jacqueline French, M.D.: Vice President for Clinical Research; Chair, Scientific Advisory Board; Professor of Neurology, NYU Comprehensive Epilepsy Center, New York University; Director Epilepsy Study Consortium
• Brian Litt, M.D.
  Assistant Professor of Neurology, Assistant Professor of Bioengineering, University of Pennsylvania
• Daniel H. Lowenstein, M.D.
  Professor of Neurology and Director, UCSF Epilepsy Program, University of California, San Francisco
• Roger J. Porter, M.D.
  Chief Scientific Officier, Epilepsy Therapy Project
• Steven C. Schachter, M.D.
  Professor of Neurology and Director of Research, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center

Continue to: Business Advisory Board